260 related articles for article (PubMed ID: 23729669)
1. Inducible interleukin 32 (IL-32) exerts extensive antiviral function via selective stimulation of interferon λ1 (IFN-λ1).
Li Y; Xie J; Xu X; Liu L; Wan Y; Liu Y; Zhu C; Zhu Y
J Biol Chem; 2013 Jul; 288(29):20927-20941. PubMed ID: 23729669
[TBL] [Abstract][Full Text] [Related]
2. IL-27, a cytokine, and IFN-λ1, a type III IFN, are coordinated to regulate virus replication through type I IFN.
Cao Y; Zhang R; Zhang W; Zhu C; Yu Y; Song Y; Wang Q; Bai L; Liu Y; Wu K; Wu J
J Immunol; 2014 Jan; 192(2):691-703. PubMed ID: 24337382
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-548 down-regulates host antiviral response via direct targeting of IFN-λ1.
Li Y; Xie J; Xu X; Wang J; Ao F; Wan Y; Zhu Y
Protein Cell; 2013 Feb; 4(2):130-41. PubMed ID: 23150165
[TBL] [Abstract][Full Text] [Related]
4. Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model.
Wu J; Huang S; Zhao X; Chen M; Lin Y; Xia Y; Sun C; Yang X; Wang J; Guo Y; Song J; Zhang E; Wang B; Zheng X; Schlaak JF; Lu M; Yang D
J Virol; 2014 Sep; 88(18):10421-31. PubMed ID: 24920792
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z
Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-21 inhibits HBV replication in vitro.
Li HJ; Kang FB; Li BS; Yang XY; Zhang YG; Sun DX
Antivir Ther; 2015; 20(6):583-90. PubMed ID: 25774942
[TBL] [Abstract][Full Text] [Related]
7. Interferon-induced polarization of M1 macrophages mediates antiviral activity against the hepatitis B virus via the hepcidin-ferroportin axis.
Liu Q; Li J; Zong Q; Duan Z; Liu F; Duan W; Ruan M; Zhang H; Liu Y; Zhou Q; Wang Q
Int Immunopharmacol; 2024 Jun; 134():112219. PubMed ID: 38733823
[TBL] [Abstract][Full Text] [Related]
8. Intracellular interleukin-32γ mediates antiviral activity of cytokines against hepatitis B virus.
Kim DH; Park ES; Lee AR; Park S; Park YK; Ahn SH; Kang HS; Won JH; Ha YN; Jae B; Kim DS; Chung WC; Song MJ; Kim KH; Park SH; Kim SH; Kim KH
Nat Commun; 2018 Aug; 9(1):3284. PubMed ID: 30115930
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-34 inhibits hepatitis B virus replication in vitro and in vivo.
Cheng ST; Tang H; Ren JH; Chen X; Huang AL; Chen J
PLoS One; 2017; 12(6):e0179605. PubMed ID: 28614380
[TBL] [Abstract][Full Text] [Related]
10. Entecavir-induced interferon-λ1 suppresses type 2 innate lymphoid cells in patients with hepatitis B virus-related liver cirrhosis.
Wang SQ; Shen Y; Li J; Liu Y; Cheng LS; Wu SD; She WM; Jiang W
J Viral Hepat; 2021 May; 28(5):795-808. PubMed ID: 33482039
[TBL] [Abstract][Full Text] [Related]
11. RIG-I enhances interferon-α response by promoting antiviral protein expression in patients with chronic hepatitis B.
Wu S; Lin J; Fu Y; Ou Q
Antivir Ther; 2018; 23(7):575-583. PubMed ID: 29790851
[TBL] [Abstract][Full Text] [Related]
12. IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System.
Aboulnasr F; Hazari S; Nayak S; Chandra PK; Panigrahi R; Ferraris P; Chava S; Kurt R; Song K; Dash A; Balart LA; Garry RF; Wu T; Dash S
PLoS One; 2015; 10(12):e0141655. PubMed ID: 26657215
[TBL] [Abstract][Full Text] [Related]
13. Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo.
Leong CR; Funami K; Oshiumi H; Mengao D; Takaki H; Matsumoto M; Aly HH; Watashi K; Chayama K; Seya T
Oncotarget; 2016 Oct; 7(42):68179-68193. PubMed ID: 27626689
[TBL] [Abstract][Full Text] [Related]
14. Effect of interferon-lambda on replication of hepatitis B virus in human hepatoma cells.
Hong SH; Cho O; Kim K; Shin HJ; Kotenko SV; Park S
Virus Res; 2007 Jun; 126(1-2):245-9. PubMed ID: 17451832
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells.
Wu J; Meng Z; Jiang M; Pei R; Trippler M; Broering R; Bucchi A; Sowa JP; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF
Hepatology; 2009 Apr; 49(4):1132-40. PubMed ID: 19140219
[TBL] [Abstract][Full Text] [Related]
16. A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus.
Zhang Y; Cobleigh MA; Lian JQ; Huang CX; Booth CJ; Bai XF; Robek MD
Gastroenterology; 2011 Nov; 141(5):1897-906. PubMed ID: 21708106
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice.
Cavanaugh VJ; Guidotti LG; Chisari FV
J Virol; 1997 Apr; 71(4):3236-43. PubMed ID: 9060687
[TBL] [Abstract][Full Text] [Related]
18. Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection.
Hösel M; Quasdorff M; Wiegmann K; Webb D; Zedler U; Broxtermann M; Tedjokusumo R; Esser K; Arzberger S; Kirschning CJ; Langenkamp A; Falk C; Büning H; Rose-John S; Protzer U
Hepatology; 2009 Dec; 50(6):1773-82. PubMed ID: 19937696
[TBL] [Abstract][Full Text] [Related]
19. Increased interleukin-32, interleukin-1, and interferon-γ levels in serum from hepatitis B patients and in HBV-stimulated peripheral blood mononuclear cells from healthy volunteers.
Tian ZJ; Shen Y; Li XR; Wei YN; Fan H; Ren QK
J Infect Public Health; 2019; 12(1):7-12. PubMed ID: 30006119
[TBL] [Abstract][Full Text] [Related]
20. The anti-HBV effect mediated by a novel recombinant eukaryotic expression vector for IFN-α.
Yu H; Hou Z; Han Q; Zhang C; Zhang J
Virol J; 2013 Aug; 10():270. PubMed ID: 23984795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
